Medicare Enrolled

Dr. Rita Raturi, MD

Rheumatology · Zephyrhills, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
38051 MARKET SQUARE DR STE 220, Zephyrhills, FL 33542
8137821234
In practice since 2014 (12 years)
NPI: 1285052852 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Raturi from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Raturi? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Raturi

Dr. Rita Raturi is a rheumatology specialist in Zephyrhills, FL, with 12 years of NPI registration. Based on federal Medicare data, Dr. Raturi performed 4,432 Medicare services across 304 unique beneficiaries.

Between the years covered by Open Payments, Dr. Raturi received a total of $16,972 from 42 pharmaceutical and/or device companies across 875 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Raturi is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 12 years in practice ▲ 4,432 Medicare services $16,972 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 131241 Clear January 31, 2027
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary

Medicare Utilization ↗
4,432
Medicare services
Bottom 48% in FL for rheumatology
304
Unique beneficiaries
$27
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~369 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Denosumab injection (Prolia/Xgeva) 2,520 $17 $24
Abatacept infusion (Orencia) 1,475 $32 $43
Office visit, established patient (20-29 min) 145 $59 $98
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 105 $54 $76
Administration of chemotherapy into vein, 1 hour or less 66 $96 $137
Office visit, established patient (30-39 min) 46 $93 $139
New patient office visit (45-59 min) 38 $103 $182
Blood draw (venipuncture) 37 $3 $3
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
33.3% high complexity
60.7% medium
6.0% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$16,972
Total received (2018-2024)
Avg $2,425/year across 7 years
Top 29% in FL for rheumatology
42
Companies
875
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$16,972 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$3,476
2023
$3,260
2022
$3,124
2021
$3,434
2020
$2,040
2019
$914
2018
$724

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,616
Janssen Biotech, Inc.
$1,825
UCB, Inc.
$1,388
PFIZER INC.
$1,129
Novartis Pharmaceuticals Corporation
$1,129
GlaxoSmithKline, LLC.
$873
Horizon Therapeutics plc
$871
ABBVIE INC.
$659
Lilly USA, LLC
$651
Alexion Pharmaceuticals, Inc.
$573
AstraZeneca Pharmaceuticals LP
$568
ANI Pharmaceuticals, Inc.
$550
Boehringer Ingelheim Pharmaceuticals, Inc.
$472
Genentech USA, Inc.
$465
GENZYME CORPORATION
$423
Aurinia Pharma U.S., Inc.
$372
E.R. Squibb & Sons, L.L.C.
$295
AbbVie Inc.
$250
Janssen Scientific Affairs, LLC
$232
Celgene Corporation
$231
Sobi, Inc
$181
Mallinckrodt Hospital Products Inc.
$159
SOBI, INC
$141
Sandoz Inc.
$139
AbbVie, Inc.
$137
Radius Health, Inc.
$116
Fresenius Kabi USA, LLC
$68
Organon LLC
$65
Bioventus LLC
$59
Kiniksa Pharmaceuticals International, plc
$59
Actelion Pharmaceuticals US, Inc.
$36
SCILEX PHARMACEUTICALS INC.
$30
Merck Sharp & Dohme Corporation
$30
TerSera Therapeutics LLC
$27
Antares Pharma, Inc.
$25
Hikma Pharmaceuticals USA
$22
Kyowa Kirin, Inc.
$20
Zimmer Biomet Holdings, Inc.
$19
Flexion Therapeutics, Inc.
$18
Almatica Pharma LLC
$18
Ultragenyx Pharmaceutical Inc.
$18
Takeda Pharmaceuticals U.S.A., Inc.
$17
Top 3 companies account for 34.3% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AVSOLA · Actemra · Arcalyst · BENLYSTA · COSENTYX · CUVITRU · CYLTEZO · Cimzia · Crysvita · DUROLANE · Durolane · EVENITY · EVUSHELD · Enbrel · Gel-One Cross-linked Hyaluronate · HUMIRA · HYRIMOZ · Humira · IDACIO · ILARIS · INFLECTRA · KEVZARA · KINERET · KRYSTEXXA · Kineret · LUPKYNIS · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OPSUMIT · ORENCIA · OTREXUP · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rituxan · SAPHNELO · SIMPONI ARIA · SKYRIZI · STRENSIQ · Soliris · Strensiq · TALTZ · TAVNEOS · TERIPARATIDE · TREMFYA · Tavneos · Tymlos · UBRELVY · XELJANZ · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $383 per 100 Medicare services performed
Looking for a rheumatology specialist in Zephyrhills?
Compare rheumatologists in the Zephyrhills area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists within 10 mi
33
Per 100K population
5.6
County median income
$67,384
Nearest hospital
Adventhealth Zephyrhills
2.7 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Raturi is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Raturi experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Raturi performed 2,520 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Raturi receive payments from pharmaceutical companies?
Yes. Dr. Raturi received a total of $16,972 from 42 companies across 875 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Raturi's costs compare to other rheumatologists in Zephyrhills?
Dr. Raturi's average Medicare payment per service is $27. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Raturi) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →